a developer of therapeutics for eye diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with OMER. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then OMER could also see price increases.
Ticker / NAME | Correlation To ALDX | 1D Price Change % | ||
---|---|---|---|---|
ALDX | 100% | +0.61% | ||
OMER - ALDX | 48% Loosely correlated | -5.70% | ||
OLMA - ALDX | 36% Loosely correlated | -3.81% | ||
RLAY - ALDX | 34% Loosely correlated | -4.71% | ||
SANA - ALDX | 31% Poorly correlated | -7.44% | ||
BMRN - ALDX | 30% Poorly correlated | +0.42% | ||
More |
Ticker / NAME | Correlation To ALDX | 1D Price Change % |
---|---|---|
ALDX | 100% | +0.61% |
drugs theme (265 stocks) | 32% Poorly correlated | +5.37% |
eye theme (8 stocks) | 30% Poorly correlated | +1.77% |
biotechnology theme (248 stocks) | 25% Poorly correlated | +5.56% |